SynthesisPharmacoEconomics2026

Comparative Economic Evaluations of CAR-T Therapies for Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Systematic Review.

Tien Hoang Tran et al.PubMed ↗Publisher ↗

No numbers read from the abstract.